Barrington Research Initiates Coverage On Bioventus with Outperform Rating, Announces Price Target of $13
Benzinga Newsdesk 9 months ago
NewsPrice TargetInitiationAnalyst Ratings
Barrington Research analyst Michael Petusky initiates coverage on Bioventus (NASDAQ:BVS) with a Outperform rating and announces Price Target of $13.
Barrington Research analyst Michael Petusky initiates coverage on Bioventus (NASDAQ:BVS) with a Outperform rating and announces Price Target of $13.